期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
中药黄芪当归合剂对肾病综合征肾损伤的保护作用及对代谢紊乱的影响 被引量:122
1
作者 王海燕 李惊子 +6 位作者 潘缉圣 邹万忠 李晓玫 章友康 朱世乐 黄海长 王叔咸 《北京大学学报(医学版)》 CAS CSCD 北大核心 2002年第5期542-552,共11页
为明确黄芪、当归在肾病综合征 (nephroticsyndrome ,NS)治疗中的作用、适应证及其作用机制 ,我们从临床和实验两方面进行了系统的研究。 (1)黄芪当归合剂对肾脏的保护作用 :各种肾脏疾病慢性病变经过肾硬化、纤维化 ,最终发展成为终末... 为明确黄芪、当归在肾病综合征 (nephroticsyndrome ,NS)治疗中的作用、适应证及其作用机制 ,我们从临床和实验两方面进行了系统的研究。 (1)黄芪当归合剂对肾脏的保护作用 :各种肾脏疾病慢性病变经过肾硬化、纤维化 ,最终发展成为终末期肾衰竭。如何阻断这一发展通路已成为国际肾脏病界研究的热点。本研究选用慢性嘌呤霉素肾病模型 ,以目前公认具有肾脏保护作用的血管紧张素转化酶抑制剂 (ACEI)作为阳性对照 ,经 12周给药观察后处死 ,收集血、尿、肾脏标本进行检测。结果显示模型鼠肾脏呈慢性炎症 ,肾小球硬化和小管间质纤维化。黄芪当归合剂 (A&A)治疗明显减轻肾功能恶化和组织学损伤 ,肾小球硬化指数和小管间质损伤指数下降与肾功能损伤减轻呈正相关 (r=0 .80 ,P <0 .0 0 1和r=0 .85 ,P <0 .0 0 1)。细胞外基质Ⅲ、Ⅳ型胶原 ,纤连蛋白和层粘连蛋白明显减少。这种抗纤维化作用与ACEI相似 ,但肾局部的血管紧张素Ⅱ水平不下降 (5 6 .5 3± 7.0 3vs 76 .6 2± 12 .88pg/mg蛋白 ,P <0 .0 5 )。然而 ,A&A治疗组的肾脏转化生长因子 β1(TGF β1) (0 .0 5 17± 0 .0 2 4 8vs 0 .110 0± 0 .0 2 6 1,P <0 .0 5 )和骨桥蛋白 (OPN ,0 .0 10 5± 0 .0 0 5 3vs 0 .115± 0 .0 34,P <0 .0 5 )表达 ,单核 展开更多
关键词 肾变病综合征 中医药疗法 黄芪 当归 药理学
在线阅读 下载PDF
结缔组织生长因子促纤维化作用及其表达调节的研究进展 被引量:15
2
作者 杨敏 黄海长 王海燕 《中国病理生理杂志》 CAS CSCD 北大核心 2005年第1期199-202,208,共5页
Connective tissue growth factor (CTGF) has recently received much attention as a possible key determinant of progressive fibrosis. It promotes tissue fibrosis through different pathways, such as cell proliferation, ex... Connective tissue growth factor (CTGF) has recently received much attention as a possible key determinant of progressive fibrosis. It promotes tissue fibrosis through different pathways, such as cell proliferation, extracellular matrix accumulation and cell transdifferentiation. A number of regulators of CTGF expression have been identified, including transforming growth factor β, vascular endothelial growth factor, tumor necrosis factor α, etc. The mechanism of profibrotic effect by CTGF was reviewed. [ 展开更多
关键词 结缔组织生长因子 纤维化 转化生长因子Β
在线阅读 下载PDF
腹膜表面层和腹膜通透性的关系 被引量:1
3
作者 汪涛 《北京大学学报(医学版)》 CAS CSCD 北大核心 2002年第5期471-473,共3页
Increase in peritoneal membrane permeabil ity is not uncommon in long-t erm peritoneal dialysis patients. It has been shown that increased peritoneal me mbrane permeability is associated with increased mortality in th... Increase in peritoneal membrane permeabil ity is not uncommon in long-t erm peritoneal dialysis patients. It has been shown that increased peritoneal me mbrane permeability is associated with increased mortality in this patient popul ation. We have been thus focused on the pathogenesis of the abnormal peritoneal membrane permeability. It was hypothesized that increased membrane permeability might be due to (1)neoangiogenesis; (2)chronic inflammation; (3)increased hydrau lic permeability of the peritoneal membrane. We have, however, found that increa se d membrane hydraulic permeability may be the key mechanism. We found that the pe ritoneal surface layer, the key component that determines the tissue hydraulic p ermeability, was rich in hyaluronan, phospholipids and surfactant proteins. Dama ging the peritoneal surface layer by shaking the peritoneal cavity, washing, add ing pentobarbital or deoxycholic acid or hyaluronidase or phospholipidase, we ha ve sig nificantly increased the membrane permeability. On the contrary, by adding hyalu r onan, phospholipids or steroid to increase the formation of the peritoneal surfa ce layer, we have decreased significantly the peritoneal permeability. Our resea rch work on this issue has been well recognized and appreciated by the interna tional society. 展开更多
关键词 腹膜 腹膜透析 膜通透性 透明质酸 表面层
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部